Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2066505
Reference Type
Technical Report
Title
Hyperuricemia, renal failure, and elevated creatine phosphokinase after amoxapine overdose
Author(s)
Thompson, M; Dempsey, W
Year
1983
Report Number
IPA/84/563022
Volume
Pharm
Issue
REF 10
Page Numbers
579-581
Language
eng
Abstract
IPA COPYRIGHT: ASHP A case is reported of hyperuricemia, acute renal failure, and elevated creatine phosphokinase in a 24-yr-old male who ingested amoxapine (I) 4 g (40 tablets of 100 mg) 12-18 h prior to hospital admission. Treatment for a generalized seizure consisted of phenytoin sodium 500 mg IV; magnesium sulfate 30 g administered by nasogastric tube; and naloxone hydrochloride 0.4 mg IV. Subsequent therapy followed with allopurinol, sodium bicarbonate, acetazolamide, aluminum hydroxide, and furosemide. The patient was awake and able to respond to questioning on the seventh day. Brief awakenings had occurred after 2 doses of physostigmine salicylate during this time. Normal renal status and laboratory values were evident in a one month follow-up. It was concluded that further research is needed to determine the pathogenesis leading to acute renal failure and high creatine phosphokinase values after amoxapine overdose.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity